- Home
- BFS vs QURE Comparison
BFS vs QURE Comparison
Compare BFS & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFS | QURE |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | United States | Netherlands |
| Employees | 98 | 248 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 902.2M | 1.1B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | BFS | QURE |
|---|---|---|
| Price | $36.70 | $40.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $44.00 | ★ $45.00 |
| AVG Volume (30 Days) | 99.3K | ★ 2.9M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.92% | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,107,000.00 |
| Revenue This Year | $0.30 | $126.12 |
| Revenue Next Year | $5.67 | $200.43 |
| P/E Ratio | $30.48 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.16 | $8.73 |
| 52 Week High | $38.42 | $71.50 |
Technical Indicators
Market Signals| Indicator | BFS | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 51.94 |
| Support Level | $32.56 | $39.50 |
| Resistance Level | $38.25 | $50.47 |
| Average True Range (ATR) | 0.77 | 2.49 |
| MACD | -0.11 | -1.21 |
| Stochastic Oscillator | 52.88 | 17.71 |
Price Performance
Historical ComparisonAbout BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.